Skip to main content
  • English
  • Español
Home
  • Company
    • Overview & History
    • Team
    • Join Oryzon
  • Epigenetics
    • Histone Code Hypothesis
    • Modulator Enzymes
    • LSD1 & Disease
    • Technology Platforms
    • Scientific Publications by Oryzon
  • Therapeutic Programs
    • Strategy
    • LSD1 & Cancer
    • LSD1 & CNS
    • Oryzon's Pipeline
  • Collaborative Research
    • Collaborative Projects
  • For Patient
    • Patient Information
  • Shareholders and Investors
    • Investor Information and News
    • Share Information
    • Events & Presentations
    • Financial Information & Downloads
    • Analyst Coverage
    • Corporate Governance
    • Corporate Social Responsibility
  • News & Press Releases
  • Contact
    • General Contact
    • Investor Contact
    • Email Alerts

investors

Shareholders and Investors

  • Investor Information and News
  • Share Information
  • Events & Presentations
  • Financial Information & Downloads
  • Analyst Coverage
  • Corporate Governance
  • Corporate Social Responsibility
  • Share Performance
  • Shares and Capital Structure
  • Dividends
  • Share Issues
  • Takeover Bids
  • Significant shareholdings and stake in own shares

Share Information

Oryzon Genomics, S.A. has created this section so that you may consult the information regarding your shares.

  • Español
Shares and capital structure

Shares and Capital Structure

Dividends Icon

Dividends

Share Performance Icon

Share Performance

Share Holdings Icon

Shareholdings

Analyst Coverage Icon

Analyst Coverage

Email Alert Icon

Email Alert Service


Stock Evolution

epigen-logo

Epigenetic drugs for a better world.

United States

Oryzon Corporate
245 First Street, Suite 1800
Cambridge, MA 02142

T: (617) 444-8786
F: (617) 444- 8405
info@oryzon.com

Spain

Oryzon Genomics
Sant Ferran 74
08940 Cornellà de Llobregat, Barcelona, Spain

T: (+34) 93 515 1313
F: (+34) 93 377 4028
info@oryzon.com

Legal Advice
Privacy Policy

Investor Information

ISIN: ES0167733015 - ORY

Please contact us for investor information.

Contact Us

© 2019

Oryzon Genomics

All Rights Reserved

  • Legal Advice
  • Privacy Policy
  • Registered address: Carrera de San Jerónimo 15, 2ª planta, 28014 Madrid (Spain)